Guizhen Wu to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Guizhen Wu has written about Drug Evaluation, Preclinical.
Connection Strength
0.089
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.089